Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Preferences help
enabled [disable] Abstract
Number of results

Results found: 1

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

Search:
in the keywords:  paranasal sinus neoplasm
help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
EN
Introduction Sinonasal cancer is very rare and accounts for under 1% of all malignancies of which sinonasal adenoid cystic carcinoma (SNACC) is about 5%. The maxillary sinus is the most common site of SNACC. Misleading symptomatology which overlaps with rhinosinusitis contributes to the delay of diagnosis. Recently, the endoscopic approach is commonly applied with equal or better results to the open approach. Radiofrequency coblation might be used to reduce blood loss. Material and Methods We present a case of an adenoid cystic carcinoma arising from the left inferior turbinate. The patient received endoscopic surgical treatment with the application of radiofrequency coblation in Clarós Clinic at the beginning of 2019 and remains followed up with no sign of recurrence. Afterward, we review the literature on the subject. Conclusion SnACC is a rare malignancy, characterized by slow growth and perineural infiltration with spreading towards the skull base, cavernous sinus, and orbit. The regional nodal involvement is rare. Frequent and delayed distant metastasis in lung, bone, liver, and brain are also typical. Prognosis is poor with the 5-year overall survival between 41%-86%. Surgery with or without complementary radiotherapy provides the best outcomes for the majority of patients. The significance of prognostic factors remains unclear. Lifelong surveillance is obligatory as very late recurrences are common.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.